 In this study, researchers have demonstrated the potential of gold nanoparticles, AUNPs, derived from the flower extract of catharanthus rosus, CR, for use in treating cervical cancer. They found that these particles can be used to deliver drugs to cancerous cells, where they cause them to undergo apoptosis, or programmed cell death. This process is initiated by the release of reactive oxygen species, ROS, which are generated by the particles themselves. These ROS then trigger a series of events leading to the activation of mitochondria, which ultimately causes the cancer cells to die. This article was authored by Yankou, Muhammad Saleh al-Aboudi, Well Al-Tuaiki, and others.